Abstract

The DNA Damage Response (DDR) is a complex signaling network that comes into play when cells experience genotoxic stress. Upon DNA damage, cellular signaling pathways are rewired to slow down cell cycle progression and allow recovery. However, when the damage is beyond repair, cells activate complex and still not fully understood mechanisms, leading to a complete proliferative arrest or cell death. Several conventional and novel anti-neoplastic treatments rely on causing DNA damage or on the inhibition of the DDR in cancer cells. However, the identification of molecular determinants directing cancer cells toward recovery or death upon DNA damage is still far from complete, and it is object of intense investigation. SPRY-containing RAN binding Proteins (Scorpins) RANBP9 and RANBP10 are evolutionarily conserved and ubiquitously expressed proteins whose biological functions are still debated. RANBP9 has been previously implicated in cell proliferation, survival, apoptosis and migration. Recent studies also showed that RANBP9 is involved in the Ataxia Telangiectasia Mutated (ATM) signaling upon DNA damage. Accordingly, cells lacking RANBP9 show increased sensitivity to genotoxic treatment. Although there is no published evidence, extensive protein similarities suggest that RANBP10 might have partially overlapping functions with RANBP9. Like RANBP9, RANBP10 bears sites putative target of PIK-kinases and high throughput studies found RANBP10 to be phosphorylated following genotoxic stress. Therefore, this second Scorpin might be another overlooked player of the DDR alone or in combination with RANBP9. This review focuses on the relatively unknown role played by RANBP9 and RANBP10 in responding to genotoxic stress.

Highlights

  • The DNA damage response (DDR) is an attractive target for anti-cancer treatments due to the increased genotoxic stress that malignant cells experience [1,2]

  • Genotoxic stress caused by cisplatin, Ultra Violet (UV)-light, osmotic shock and Ionizing Radiation (IR) cell exposure [26,36] leads to RAN Binding Protein 9 (RANBP9) phosphorylation by kinases that have been identified only to a limited extent

  • RAN Binding Protein 10 (RANBP10) is expressed at lower levels compared to RANBP9 and it was shown that RANBP10 was not able to increase activation of the RAS/ERK pathway like its paralog, but was competing for the binding of cMET at the membrane and inhibiting the kinase signaling mediated by RANBP9 [16]

Read more

Summary

Introduction

The DNA damage response (DDR) is an attractive target for anti-cancer treatments due to the increased genotoxic stress that malignant cells experience [1,2]. They find ways to reactivate targeted/inactivated proteins or resort to alternative pathways guarantying DNA repair at levels compatible with survival and proliferation [2,5]. For these reasons, finding vulnerabilities that are specific to cancer cells sparing normal ones has proven to be challenging [2,5]. SPRY-containing RAN binding Proteins (Scorpins) RANBP9 and RANBP10 are two highly similar proteins whose biological functions are poorly understood. This inadequate knowledge is due to multiple causes including the lack of validated antibodies able to discriminate between the two proteins. This review focuses on the relatively unknown role of Scorpins in responding to genotoxic stress

Scorpins
RANBP9 in the DDR
RANBP9 and Post-Translational Modifications Following Stress
RANBP9 Protein-Protein Interactions Relevant to the DDR
Known Biological Roles of RANBP10
RANBP10 in the DDR
Future Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call